MwanzoORCHPHARMA • NSE
add
Orchid Pharma Ltd
Bei iliyotangulia
₹ 714.30
Bei za siku
₹ 715.15 - ₹ 749.10
Bei za mwaka
₹ 603.80 - ₹ 1,997.40
Thamani ya kampuni katika soko
37.51B INR
Wastani wa hisa zilizouzwa
elfu 197.26
Uwiano wa bei na mapato
37.63
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 2.37B | 9.39% |
Matumizi ya uendeshaji wa biashara | 803.51M | 65.13% |
Mapato halisi | 222.95M | -33.50% |
Kiwango cha faida halisi | 9.39 | -39.18% |
Mapato kwa kila hisa | 4.40 | — |
EBITDA | 277.48M | -6.06% |
Asilimia ya kodi ya mapato | -0.18% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.80B | 4,868.40% |
Jumla ya mali | 16.88B | 8.63% |
Jumla ya dhima | 4.21B | 9.42% |
Jumla ya hisa | 12.67B | — |
hisa zilizosalia | 50.67M | — |
Uwiano wa bei na thamani | 2.86 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 3.38% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 222.95M | -33.50% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Ilianzishwa
1992
Tovuti
Wafanyakazi
871